Background/Aim: Extraordinary restrictions aimed to limit Sars-CoV-2 spreading; they imposed a total reorganization of the health-system. Oncological treatments experienced a significant slowdown. The aim of our multicentric retrospective study was to evaluate screening suspension and surgical treatment delay during COVID-19 and the impact on breast cancer presentation. Patients and Methods: All patients who underwent breast surgery from March 11, 2020 to May 30, 2020 were evaluated and considered as the Lockdown group. These patients were compared with similar patients of the previous year, the Pre-Lockdown group. Results: A total of 432 patients were evaluated; n=223 and n=209 in the Lockdown.

Delay in breast cancer treatments during the first COVID-19 lockdown. a multicentric analysis of 432 patients / Vanni, G.; Tazzioli, G.; Pellicciaro, M.; Materazzo, M.; Paolo, O.; Cattadori, F.; Combi, F.; Papi, S.; Pistolese, C. A.; Cotesta, M.; Santori, F.; Caspi, J.; Chiaravalloti, A.; Muscoli, S.; Lombardo, V.; Grasso, A.; Caggiati, L.; Raselli, R.; Palli, D.; Altomare, V.; D'Angelillo, R. M.; Palombi, L.; Buonomo, O. C.. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - 40:12(2020), pp. 7119-7125. [10.21873/anticanres.14741]

Delay in breast cancer treatments during the first COVID-19 lockdown. a multicentric analysis of 432 patients

Tazzioli G.
Membro del Collaboration Group
;
Combi F.
Membro del Collaboration Group
;
Papi S.
Membro del Collaboration Group
;
2020

Abstract

Background/Aim: Extraordinary restrictions aimed to limit Sars-CoV-2 spreading; they imposed a total reorganization of the health-system. Oncological treatments experienced a significant slowdown. The aim of our multicentric retrospective study was to evaluate screening suspension and surgical treatment delay during COVID-19 and the impact on breast cancer presentation. Patients and Methods: All patients who underwent breast surgery from March 11, 2020 to May 30, 2020 were evaluated and considered as the Lockdown group. These patients were compared with similar patients of the previous year, the Pre-Lockdown group. Results: A total of 432 patients were evaluated; n=223 and n=209 in the Lockdown.
2020
40
12
7119
7125
Delay in breast cancer treatments during the first COVID-19 lockdown. a multicentric analysis of 432 patients / Vanni, G.; Tazzioli, G.; Pellicciaro, M.; Materazzo, M.; Paolo, O.; Cattadori, F.; Combi, F.; Papi, S.; Pistolese, C. A.; Cotesta, M.; Santori, F.; Caspi, J.; Chiaravalloti, A.; Muscoli, S.; Lombardo, V.; Grasso, A.; Caggiati, L.; Raselli, R.; Palli, D.; Altomare, V.; D'Angelillo, R. M.; Palombi, L.; Buonomo, O. C.. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - 40:12(2020), pp. 7119-7125. [10.21873/anticanres.14741]
Vanni, G.; Tazzioli, G.; Pellicciaro, M.; Materazzo, M.; Paolo, O.; Cattadori, F.; Combi, F.; Papi, S.; Pistolese, C. A.; Cotesta, M.; Santori, F.; Caspi, J.; Chiaravalloti, A.; Muscoli, S.; Lombardo, V.; Grasso, A.; Caggiati, L.; Raselli, R.; Palli, D.; Altomare, V.; D'Angelillo, R. M.; Palombi, L.; Buonomo, O. C.
File in questo prodotto:
File Dimensione Formato  
Delay in breast cancer treatments during the first COVID-19.pdf

Open access

Descrizione: Articolo principale
Tipologia: Versione pubblicata dall'editore
Dimensione 134.85 kB
Formato Adobe PDF
134.85 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1225929
Citazioni
  • ???jsp.display-item.citation.pmc??? 38
  • Scopus 70
  • ???jsp.display-item.citation.isi??? 64
social impact